Caption Management, LLC Cabaletta Bio, Inc. Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $1.13 Million - $2.94 Million	-156,111 Reduced 97.57%	3,889 $29,000
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $2.04 Million - $3.09 Million	121,700 Added 317.75%	160,000 $2.73 Million
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $467,643 - $894,688	38,300 New	38,300 $869,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $2.11 $52,222 - $111,302	-52,750 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.36 - $14.64 $177,240 - $772,260	52,750 New	52,750 $200,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.